Epizyme Inc. (EPZM) NASDAQ
$1.47 - (-)
Market Cap: -
As of 08/11/22 12:00 AM EDT. Market closed.
Epizyme Inc. (EPZM)
NASDAQ
$1.47
- (-)
Market Cap: -
As of 08/11/22 12:00 AM EDT. Market closed.
Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. In addition to an active research and discovery pipeline, Epizyme has one U.S. FDA approved product, TAZVERIK® (tazemetostat), for the treatment of adults and pediatric patients aged 16 years and ... read more
Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. In addition to an active research and discovery pipeline, Epizyme has one U.S. FDA approved product, TAZVERIK® (tazemetostat), for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma (ES) who are not eligible for complete resection; adult patients with relapsed or refractory follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least two prior systemic therapies; and adult patients with relapsed or refractory follicular lymphoma who have no satisfactory alternative treatment options. These indications are approved under accelerated approval based on overall response rate and duration of response. Continued approval for these indications may be contingent upon verification and description of clinical benefit in confirmatory trials. The Company is also exploring the treatment potential of tazemetostat in investigational clinical trials in other solid tumors and hematological malignancies, as a monotherapy and combination therapy in both relapsed and front-line disease settings. By focusing on the genetic drivers of disease, Epizyme seeks to match medicines with the patients who need them.. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Bogle Grant C. | See Remarks | Aug 09, 2022 | Option Exercise | $1.40 | 1,141,390 | 1,594,434 | 259,170 | Aug 11, 2022, 09:00 PM |
Bogle Grant C. | See Remarks | Aug 09, 2022 | Option Exercise | $1.40 | 1,217,500 | 1,700,675 | 983,060 | Aug 11, 2022, 09:00 PM |
Agarwal Shefali | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 373,154 | 518,684 | 285,562 | Aug 11, 2022, 08:53 PM |
Agarwal Shefali | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 500,000 | 695,000 | 658,716 | Aug 11, 2022, 08:53 PM |
Beaulieu Joseph | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 279,864 | 389,011 | 51,099 | Aug 11, 2022, 08:53 PM |
Beaulieu Joseph | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 300,000 | 417,000 | 330,963 | Aug 11, 2022, 08:53 PM |
Kutok Jeffery | Chief Scientific Officer | Aug 09, 2022 | Option Exercise | $1.39 | 354,496 | 492,749 | 120,067 | Aug 11, 2022, 08:52 PM |
Kutok Jeffery | Chief Scientific Officer | Aug 09, 2022 | Option Exercise | $1.39 | 380,000 | 528,200 | 474,563 | Aug 11, 2022, 08:52 PM |
MOTT DAVID M | Director | Jun 30, 2022 | Option Exercise | $1.47 | 16,156 | 23,749 | 224,488 | Jul 05, 2022, 05:06 PM |
BEVERIDGE, ROY A | Director | Jun 30, 2022 | Option Exercise | $1.47 | 8,928 | 13,124 | 46,037 | Jul 05, 2022, 05:06 PM |
Conroy Kevin T | Director | Jun 30, 2022 | Option Exercise | $1.47 | 10,204 | 15,000 | 62,318 | Jul 05, 2022, 05:02 PM |
Kutok Jeffery | Chief Scientific Officer | Apr 11, 2022 | Sale | $0.90 | 2,741 | 2,467 | 94,563 | Apr 13, 2022, 05:49 PM |
BEVERIDGE, ROY A | Director | Mar 31, 2022 | Option Exercise | $1.15 | 11,413 | 13,125 | 28,115 | Apr 01, 2022, 05:31 PM |
MOTT DAVID M | Director | Mar 31, 2022 | Option Exercise | $1.15 | 20,653 | 23,751 | 199,338 | Apr 01, 2022, 05:30 PM |
Conroy Kevin T | Director | Mar 31, 2022 | Option Exercise | $1.15 | 13,043 | 14,999 | 43,120 | Apr 01, 2022, 05:30 PM |
Beaulieu Joseph | See Remarks | Feb 28, 2022 | Option Exercise | $1.27 | 2,331 | 2,952 | 30,963 | Mar 21, 2022, 06:06 PM |
Agarwal Shefali | See Remarks | Feb 28, 2022 | Option Exercise | $1.27 | 2,331 | 2,952 | 158,716 | Mar 21, 2022, 06:05 PM |
Beaulieu Joseph | Corporate Controller | Feb 07, 2022 | Sale | $1.50 | 222 | 333 | 28,632 | Feb 09, 2022, 05:43 PM |
Agarwal Shefali | See Remarks | Feb 07, 2022 | Sale | $1.50 | 1,058 | 1,587 | 156,385 | Feb 09, 2022, 05:40 PM |
Agarwal Shefali | See Remarks | Feb 02, 2022 | Sale | $1.37 | 2,639 | 3,615 | 157,443 | Feb 04, 2022, 04:15 PM |
Kutok Jeffery | Chief Scientific Officer | Feb 02, 2022 | Sale | $1.37 | 2,556 | 3,502 | 97,304 | Feb 04, 2022, 04:15 PM |
Beaulieu Joseph | Corporate Controller | Feb 02, 2022 | Sale | $1.37 | 687 | 941 | 28,854 | Feb 04, 2022, 04:15 PM |
Legorreta Pablo G. | Director | Jan 31, 2022 | Buy | $1.50 | 22,666,667 | 34,000,001 | 31,833,334 | Feb 01, 2022, 04:17 PM |
Agarwal Shefali | See Remarks | Jan 26, 2022 | Sale | $2.02 | 2,922 | 5,902 | 160,082 | Jan 28, 2022, 04:15 PM |
Agarwal Shefali | See Remarks | Dec 06, 2021 | Sale | $2.93 | 1,780 | 5,215 | 163,004 | Dec 07, 2021, 07:03 PM |
MOTT DAVID M | Director | Sep 30, 2021 | Option Exercise | $5.12 | 4,640 | 23,757 | 169,185 | Oct 01, 2021, 04:30 PM |
Conroy Kevin T | Director | Sep 30, 2021 | Option Exercise | $5.12 | 2,930 | 15,002 | 24,077 | Oct 01, 2021, 04:30 PM |
Conroy Kevin T | Director | Jun 30, 2021 | Option Exercise | $8.31 | 1,805 | 15,000 | 21,147 | Jul 01, 2021, 04:15 PM |
MOTT DAVID M | Director | Jun 30, 2021 | Option Exercise | $8.31 | 2,858 | 23,750 | 164,545 | Jul 01, 2021, 04:15 PM |
Conroy Kevin T | Director | Mar 31, 2021 | Option Exercise | $8.71 | 1,723 | 15,007 | 11,282 | Apr 01, 2021, 07:00 PM |
MOTT DAVID M | Director | Mar 31, 2021 | Option Exercise | $8.71 | 2,727 | 23,752 | 153,627 | Apr 01, 2021, 07:00 PM |
MOTT DAVID M | Director | Mar 26, 2021 | Buy | $7.97 | 34,486 | 274,817 | 150,900 | Mar 29, 2021, 04:30 PM |
MOTT DAVID M | Director | Mar 25, 2021 | Buy | $7.98 | 28,231 | 225,283 | 116,414 | Mar 29, 2021, 04:30 PM |
Bazemore Robert B | President & CEO | Mar 25, 2021 | Sale | $7.85 | 10,328 | 81,075 | 322,626 | Mar 29, 2021, 04:30 PM |
Bazemore Robert B | President & CEO | Feb 04, 2021 | Sale | $11.21 | 3,890 | 43,607 | 331,977 | Feb 05, 2021, 04:41 PM |
Agarwal Shefali | Chief Medical Officer | Feb 04, 2021 | Sale | $11.21 | 969 | 10,862 | 104,341 | Feb 05, 2021, 04:41 PM |
TOMBESI PAOLO | Chief Financial Officer | Feb 04, 2021 | Sale | $11.21 | 1,021 | 11,445 | 53,465 | Feb 05, 2021, 04:40 PM |
Beaulieu Joseph | Corporate Controller | Feb 04, 2021 | Sale | $11.21 | 227 | 2,545 | 13,431 | Feb 05, 2021, 04:40 PM |
Ros Matthew | See Remarks | Feb 04, 2021 | Sale | $11.21 | 894 | 10,022 | 83,188 | Feb 05, 2021, 04:36 PM |
Vakiener Victoria | Chief Commercial Officer | Feb 04, 2021 | Sale | $11.21 | 817 | 9,159 | 52,685 | Feb 05, 2021, 04:32 PM |
Bazemore Robert B | President & CEO | Jan 25, 2021 | Sale | $11.41 | 6,069 | 69,247 | 248,367 | Jan 27, 2021, 08:44 PM |
Ros Matthew | See Remarks | Jan 25, 2021 | Sale | $11.41 | 2,872 | 32,770 | 55,957 | Jan 27, 2021, 08:42 PM |
Vakiener Victoria | Chief Commercial Officer | Jan 25, 2021 | Sale | $11.41 | 599 | 6,835 | 27,982 | Jan 27, 2021, 08:42 PM |
Agarwal Shefali | Chief Medical Officer | Jan 25, 2021 | Sale | $11.41 | 2,872 | 32,770 | 75,727 | Jan 27, 2021, 08:38 PM |
Conroy Kevin T | Director | Dec 31, 2020 | Option Exercise | $10.86 | 1,024 | 11,121 | 9,559 | Jan 05, 2021, 08:32 AM |
MOTT DAVID M | Director | Dec 31, 2020 | Option Exercise | $10.86 | 2,158 | 23,436 | 88,183 | Jan 05, 2021, 08:15 AM |
Agarwal Shefali | Chief Medical Officer | Dec 03, 2020 | Sale | $13.54 | 2,522 | 34,148 | 76,089 | Dec 07, 2020, 07:00 AM |
GOLDFISCHER CARL | Director | Nov 11, 2020 | Buy | $12.07 | 5,000 | 60,350 | 5,000 | Nov 13, 2020, 07:05 AM |
MOTT DAVID M | Director | Sep 30, 2020 | Option Exercise | $11.93 | 1,965 | 23,442 | 86,025 | Oct 01, 2020, 04:58 PM |
Conroy Kevin T | Director | Sep 30, 2020 | Option Exercise | $11.93 | 933 | 11,131 | 8,535 | Oct 01, 2020, 04:56 PM |
Beaulieu Joseph | Corporate Controller | Sep 03, 2019 | Sale | $12.77 | 971 | 12,400 | 6,501 | Sep 03, 2020, 09:30 PM |
Beaulieu Joseph | Corporate Controller | Sep 02, 2020 | Sale | $12.88 | 543 | 6,994 | 5,958 | Sep 03, 2020, 09:30 PM |
TOMBESI PAOLO | Chief Financial Officer | Aug 20, 2020 | Option Exercise | $12.55 | 2,091 | 26,242 | 26,906 | Aug 21, 2020, 04:15 PM |
MOTT DAVID M | Director | Jun 30, 2020 | Option Exercise | $16.06 | 1,459 | 23,432 | 84,060 | Jul 01, 2020, 05:04 PM |
Conroy Kevin T | Director | Jun 30, 2020 | Option Exercise | $16.06 | 693 | 11,130 | 7,602 | Jul 01, 2020, 04:32 PM |
Beaulieu Joseph | Corporate Controller | Jun 26, 2020 | Sale | $16.15 | 317 | 5,120 | 4,838 | Jun 30, 2020, 09:04 AM |
Bazemore Robert B | President & CEO | Jun 26, 2020 | Sale | $16.15 | 4,773 | 77,084 | 250,098 | Jun 30, 2020, 09:01 AM |
TOMBESI PAOLO | Chief Financial Officer | Jun 26, 2020 | Sale | $16.15 | 1,805 | 29,151 | 21,942 | Jun 30, 2020, 08:57 AM |
Agarwal Shefali | Chief Medical Officer | Jun 26, 2020 | Sale | $16.15 | 1,805 | 29,151 | 78,611 | Jun 30, 2020, 08:56 AM |
Ros Matthew | See Remarks | Jun 26, 2020 | Sale | $16.15 | 2,728 | 44,057 | 57,507 | Jun 30, 2020, 08:54 AM |
MOTT DAVID M | Director | Jun 26, 2020 | Buy | $16.03 | 62,019 | 994,165 | 82,601 | Jun 26, 2020, 07:12 PM |
Bazemore Robert B | President & CEO | Jun 18, 2020 | Option Exercise | $8.98 | 10,000 | 89,800 | 264,371 | Jun 22, 2020, 07:36 PM |
Bazemore Robert B | President & CEO | Jun 18, 2020 | Sale | $22.00 | 20,000 | 440,000 | 254,371 | Jun 22, 2020, 07:36 PM |
Ros Matthew | See Remarks | Jun 18, 2020 | Option Exercise | $9.47 | 112,003 | 1,060,669 | 120,449 | Jun 22, 2020, 07:31 PM |
Ros Matthew | See Remarks | Jun 18, 2020 | Sale | $21.24 | 112,003 | 2,378,444 | 51,798 | Jun 22, 2020, 07:31 PM |
MOTT DAVID M | Director | Mar 31, 2020 | Option Exercise | $15.51 | 1,512 | 23,451 | 20,582 | Apr 02, 2020, 07:02 PM |
Conroy Kevin T | Director | Mar 31, 2020 | Option Exercise | $15.51 | 717 | 11,121 | 6,909 | Apr 02, 2020, 07:00 PM |
Beaulieu Joseph | Corporate Controller | Mar 25, 2020 | Sale | $15.28 | 212 | 3,239 | 4,961 | Mar 26, 2020, 09:11 PM |
TOMBESI PAOLO | Chief Financial Officer | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 15,437 | Mar 26, 2020, 09:01 PM |
Ros Matthew | See Remarks | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 51,798 | Mar 26, 2020, 09:01 PM |
Bazemore Robert B | President & CEO | Mar 25, 2020 | Sale | $15.28 | 3,285 | 50,195 | 254,371 | Mar 26, 2020, 09:00 PM |
Agarwal Shefali | Chief Medical Officer | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 71,991 | Mar 26, 2020, 09:00 PM |
Allen Andrew R | Director | Mar 16, 2020 | Option Exercise | $9.33 | 12,500 | 116,625 | 12,500 | Mar 18, 2020, 04:30 PM |
Beaulieu Joseph | Corporate Controller | Mar 03, 2020 | Sale | $22.18 | 996 | 22,091 | 3,617 | Mar 05, 2020, 06:52 PM |
Legorreta Pablo G. | Director | Feb 11, 2020 | Option Exercise | $20.00 | 2,500,000 | 50,000,000 | 9,166,667 | Feb 13, 2020, 06:47 PM |
Agarwal Shefali | Chief Medical Officer | Jan 27, 2020 | Sale | $20.44 | 2,630 | 53,757 | 58,803 | Jan 27, 2020, 09:19 PM |
Agarwal Shefali | Chief Medical Officer | Jan 24, 2020 | Sale | $24.64 | 1,843 | 45,412 | 61,433 | Jan 27, 2020, 09:19 PM |
Ros Matthew | See Remarks | Jan 24, 2020 | Option Exercise | $22.40 | 2,395 | 53,648 | 39,790 | Jan 27, 2020, 09:18 PM |
Ros Matthew | See Remarks | Jan 24, 2020 | Sale | $24.64 | 1,847 | 45,510 | 42,185 | Jan 27, 2020, 09:18 PM |
Bazemore Robert B | President & CEO | Jan 27, 2020 | Sale | $20.44 | 6,074 | 124,153 | 84,668 | Jan 27, 2020, 09:17 PM |
Bazemore Robert B | President & CEO | Jan 24, 2020 | Sale | $24.62 | 3,002 | 73,909 | 90,742 | Jan 27, 2020, 09:17 PM |
Beaulieu Joseph | Corporate Controller | Jan 24, 2020 | Sale | $24.63 | 330 | 8,128 | 1,042 | Jan 27, 2020, 09:16 PM |
TOMBESI PAOLO | Chief Financial Officer | Jan 23, 2020 | Option Exercise | $26.72 | 1,698 | 45,371 | 3,302 | Jan 27, 2020, 09:15 PM |
MOTT DAVID M | Director | Dec 31, 2019 | Option Exercise | $24.60 | 952 | 23,419 | 19,070 | Jan 03, 2020, 04:44 PM |
Conroy Kevin T | Director | Dec 31, 2019 | Option Exercise | $24.60 | 452 | 11,119 | 6,192 | Jan 03, 2020, 04:33 PM |
MOTT DAVID M | Director | Sep 30, 2019 | Option Exercise | $10.32 | 2,271 | 23,437 | 18,118 | Oct 02, 2019, 04:54 PM |
Conroy Kevin T | Director | Sep 30, 2019 | Option Exercise | $10.32 | 1,078 | 11,125 | 5,740 | Oct 02, 2019, 04:15 PM |
MOTT DAVID M | Director | Jun 30, 2019 | Option Exercise | $12.55 | 1,868 | 23,443 | 15,847 | Jul 02, 2019, 04:28 PM |
SEIDENBERG BETH C | Director | Jun 30, 2019 | Option Exercise | $12.55 | 1,010 | 12,676 | 8,481 | Jul 02, 2019, 12:00 AM |
Conroy Kevin T | Director | Jun 30, 2019 | Option Exercise | $12.55 | 887 | 11,132 | 4,662 | Jul 02, 2019, 12:00 AM |
MOTT DAVID M | Director | Jun 27, 2019 | Sale | $12.43 | 52,473 | 652,134 | 0 | Jun 28, 2019, 07:05 PM |
MOTT DAVID M | Director | Jun 26, 2019 | Sale | $12.85 | 52,472 | 674,176 | 52,473 | Jun 26, 2019, 05:16 PM |
MOTT DAVID M | Director | Jun 25, 2019 | Sale | $13.31 | 52,472 | 698,649 | 104,945 | Jun 26, 2019, 05:16 PM |
Agarwal Shefali | Chief Medical Officer | Jun 14, 2019 | Sale | $11.97 | 1,195 | 14,304 | 35,699 | Jun 17, 2019, 05:18 PM |
Beaulieu Joseph | Corporate Controller | Jun 13, 2019 | Sale | $12.10 | 203 | 2,456 | 497 | Jun 14, 2019, 06:56 PM |
Ros Matthew | See Remarks | Jun 13, 2019 | Sale | $12.10 | 1,185 | 14,339 | 39,032 | Jun 14, 2019, 06:54 PM |
Bazemore Robert B | President & CEO | Jun 13, 2019 | Sale | $12.10 | 2,074 | 25,095 | 84,994 | Jun 14, 2019, 06:53 PM |
MOTT DAVID M | Director | Mar 31, 2019 | Option Exercise | $12.39 | 1,891 | 23,429 | 13,979 | Jun 07, 2019, 04:44 PM |
SEIDENBERG BETH C | Director | Mar 31, 2019 | Option Exercise | $12.39 | 1,024 | 12,687 | 7,471 | Jun 07, 2019, 04:29 PM |
Conroy Kevin T | Director | Mar 31, 2019 | Option Exercise | $12.39 | 897 | 11,114 | 3,775 | Jun 07, 2019, 04:25 PM |
MOTT DAVID M | Director | Oct 05, 2018 | Buy | $9.00 | 416,667 | 3,750,003 | 6,471,018 | Oct 05, 2018, 06:36 PM |
SEIDENBERG BETH C | Director | Jul 02, 2018 | Option Exercise | $13.55 | 3,247 | 43,997 | 6,447 | Jul 02, 2018, 05:42 PM |
MOTT DAVID M | Director | Jul 02, 2018 | Option Exercise | $13.55 | 6,088 | 82,492 | 12,088 | Jul 02, 2018, 05:37 PM |
Conroy Kevin T | Director | Jul 02, 2018 | Option Exercise | $13.55 | 2,878 | 38,997 | 2,878 | Jul 02, 2018, 05:34 PM |
Ros Matthew | Chief Operating Officer | Feb 05, 2018 | Option Exercise | $9.58 | 72,264 | 692,289 | 74,867 | Feb 06, 2018, 04:26 PM |
Ros Matthew | Chief Operating Officer | Feb 05, 2018 | Sale | $16.63 | 72,264 | 1,201,695 | 3,122 | Feb 06, 2018, 04:26 PM |
Ho Peter Tai-Ching | Chief Development Officer | Oct 24, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 23,123 | Oct 25, 2017, 12:29 PM |
Ho Peter Tai-Ching | Chief Development Officer | Oct 24, 2017 | Sale | $16.44 | 15,000 | 246,591 | 8,123 | Oct 25, 2017, 12:29 PM |
Ho Peter Tai-Ching | Chief Development Officer | Sep 25, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 23,123 | Sep 26, 2017, 04:46 PM |
Ho Peter Tai-Ching | Chief Development Officer | Sep 25, 2017 | Sale | $16.81 | 15,000 | 252,076 | 8,123 | Sep 26, 2017, 04:46 PM |
MOTT DAVID M | Director | Sep 18, 2017 | Buy | $15.25 | 200,000 | 3,050,000 | 6,054,351 | Sep 18, 2017, 04:27 PM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 24, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 22,228 | Aug 28, 2017, 01:39 PM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 24, 2017 | Sale | $15.68 | 15,000 | 235,266 | 7,228 | Aug 28, 2017, 01:39 PM |
Ho Peter Tai-Ching | Chief Development Officer | Jul 24, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 22,228 | Jul 26, 2017, 05:19 PM |
Ho Peter Tai-Ching | Chief Development Officer | Jul 24, 2017 | Sale | $13.44 | 15,000 | 201,571 | 7,228 | Jul 26, 2017, 05:19 PM |
Singer Andrew E. | EVP & CFO | Jun 30, 2017 | Sale | $15.50 | 3,024 | 46,872 | 40,529 | Jul 05, 2017, 12:00 AM |
Ho Peter Tai-Ching | Chief Development Officer | Jun 26, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 22,228 | Jun 27, 2017, 03:13 PM |
Ho Peter Tai-Ching | Chief Development Officer | Jun 26, 2017 | Sale | $14.87 | 15,000 | 223,115 | 7,228 | Jun 27, 2017, 03:13 PM |
Copeland Robert A | President of Research and CSO | Jun 06, 2017 | Option Exercise | $3.54 | 2,500 | 8,850 | 34,038 | Jun 07, 2017, 01:48 PM |
Copeland Robert A | President of Research and CSO | Jun 06, 2017 | Sale | $13.45 | 2,500 | 33,625 | 31,538 | Jun 07, 2017, 01:48 PM |
Ho Peter Tai-Ching | Chief Development Officer | May 25, 2017 | Option Exercise | $8.98 | 15,000 | 134,700 | 22,228 | May 26, 2017, 11:20 AM |
Ho Peter Tai-Ching | Chief Development Officer | May 25, 2017 | Sale | $16.11 | 15,000 | 241,664 | 7,228 | May 26, 2017, 11:20 AM |
Copeland Robert A | President of Research and CSO | May 02, 2017 | Option Exercise | $3.54 | 5,000 | 17,700 | 36,538 | May 03, 2017, 01:08 PM |
Copeland Robert A | President of Research and CSO | May 02, 2017 | Sale | $17.44 | 5,000 | 87,212 | 31,538 | May 03, 2017, 01:08 PM |
Copeland Robert A | President of Research and CSO | Apr 04, 2017 | Option Exercise | $3.00 | 5,000 | 15,000 | 36,538 | Apr 05, 2017, 05:44 PM |
Copeland Robert A | President of Research and CSO | Apr 04, 2017 | Sale | $16.36 | 5,000 | 81,805 | 34,038 | Apr 05, 2017, 05:44 PM |
Singer Andrew E. | EVP & CFO | Mar 31, 2017 | Sale | $17.09 | 2,013 | 34,394 | 36,175 | Apr 03, 2017, 01:55 PM |
Ros Matthew | Chief Operating Officer | Feb 28, 2017 | Option Exercise | $6.21 | 1,708 | 10,613 | 1,708 | Mar 02, 2017, 04:03 PM |
Ho Peter Tai-Ching | Chief Development Officer | Feb 28, 2017 | Option Exercise | $6.21 | 1,708 | 10,613 | 7,228 | Mar 02, 2017, 04:02 PM |
Singer Andrew E. | EVP & CFO | Jan 09, 2017 | Sale | $12.04 | 1,013 | 12,194 | 33,270 | Jan 10, 2017, 02:01 PM |
Ho Peter Tai-Ching | Chief Development Officer | Dec 08, 2016 | Sale | $10.89 | 200 | 2,179 | 5,520 | Dec 12, 2016, 02:48 PM |
Singer Andrew E. | EVP & CFO | Dec 09, 2016 | Sale | $11.03 | 1,013 | 11,172 | 31,824 | Dec 12, 2016, 02:46 PM |
Singer Andrew E. | EVP & CFO | Nov 09, 2016 | Sale | $10.40 | 1,013 | 10,535 | 30,378 | Nov 10, 2016, 09:28 PM |
Singer Andrew E. | EVP & CFO | Oct 10, 2016 | Sale | $9.72 | 1,013 | 9,848 | 28,931 | Oct 12, 2016, 01:42 PM |
Singer Andrew E. | EVP & CFO | Sep 09, 2016 | Sale | $7.55 | 1,013 | 7,651 | 27,485 | Sep 12, 2016, 08:18 PM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 31, 2016 | Option Exercise | $6.21 | 1,362 | 8,463 | 5,720 | Sep 01, 2016, 05:24 PM |
Bazemore Robert B | President & CEO | Aug 31, 2016 | Option Exercise | $6.21 | 1,362 | 8,463 | 1,362 | Sep 01, 2016, 05:22 PM |
Singer Andrew E. | EVP & CFO | Aug 09, 2016 | Sale | $9.05 | 1,013 | 9,166 | 26,039 | Aug 10, 2016, 04:43 PM |
Copeland Robert A | President of Research and CSO | Aug 01, 2016 | Option Exercise | $2.19 | 4,000 | 8,760 | 35,538 | Aug 03, 2016, 12:35 PM |
Copeland Robert A | President of Research and CSO | Aug 01, 2016 | Sale | $10.37 | 4,000 | 41,492 | 31,538 | Aug 03, 2016, 12:35 PM |
Singer Andrew E. | EVP & CFO | Jul 11, 2016 | Sale | $10.36 | 1,013 | 10,494 | 24,592 | Jul 13, 2016, 10:38 AM |
Copeland Robert A | President of Research and CSO | Jul 05, 2016 | Option Exercise | $2.19 | 4,000 | 8,760 | 4,000 | Jul 07, 2016, 10:36 AM |
Copeland Robert A | President of Research and CSO | Jul 05, 2016 | Sale | $10.03 | 4,000 | 40,128 | 0 | Jul 07, 2016, 10:36 AM |
MOTT DAVID M | Director | Jul 01, 2016 | Option Exercise | $10.33 | 6,000 | 61,980 | 6,000 | Jul 06, 2016, 05:05 PM |
SEIDENBERG BETH C | Director | Jul 01, 2016 | Option Exercise | $10.33 | 3,200 | 33,056 | 3,200 | Jul 06, 2016, 04:58 PM |
Singer Andrew E. | EVP & CFO | Jun 09, 2016 | Sale | $12.49 | 1,013 | 12,656 | 23,146 | Jun 10, 2016, 09:03 PM |
Copeland Robert A | President of Research and CSO | Jun 01, 2016 | Option Exercise | $3.54 | 31,538 | 111,645 | 31,538 | Jun 02, 2016, 01:47 PM |
Singer Andrew E. | EVP & CFO | May 09, 2016 | Sale | $9.79 | 1,013 | 9,914 | 22,096 | May 12, 2016, 11:41 AM |
Singer Andrew E. | EVP & CFO | Apr 12, 2016 | Sale | $12.14 | 173 | 2,100 | 20,253 | May 12, 2016, 08:57 AM |
Singer Andrew E. | EVP & CFO | Apr 11, 2016 | Sale | $12.48 | 840 | 10,483 | 20,426 | May 12, 2016, 08:57 AM |
Singer Andrew E. | EVP & CFO | Apr 12, 2016 | Sale | $12.14 | 173 | 2,100 | 20,253 | Apr 13, 2016, 11:02 AM |
Singer Andrew E. | EVP & CFO | Apr 11, 2016 | Sale | $12.48 | 840 | 10,483 | 20,426 | Apr 13, 2016, 11:02 AM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 20, 2015 | Buy | $16.51 | 2,000 | 33,020 | 2,200 | Mar 31, 2016, 04:33 PM |
Singer Andrew E. | EVP & CFO | Mar 09, 2016 | Sale | $9.33 | 1,006 | 9,386 | 18,907 | Mar 11, 2016, 09:45 AM |
Ho Peter Tai-Ching | Chief Development Officer | Feb 29, 2016 | Buy | $7.47 | 636 | 4,752 | 5,358 | Mar 02, 2016, 05:14 PM |
Singer Andrew E. | EVP & CFO | Feb 10, 2016 | Sale | $9.54 | 12,158 | 115,987 | 17,354 | Feb 10, 2016, 07:39 PM |
Weller Harry R | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:35 PM |
Viswanathan Ravi | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:35 PM |
SANDELL SCOTT D | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:34 PM |
MOTT DAVID M | Director | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:34 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:33 PM |
KERINS PATRICK J | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:33 PM |
BASKETT FOREST | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:32 PM |
BARRIS PETER J | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:32 PM |
BARRETT M JAMES | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:31 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 1,111,111 | 9,999,999 | 5,854,351 | Jan 12, 2016, 05:30 PM |
GOLDFISCHER CARL | Director | Jan 12, 2016 | Buy | $9.00 | 555,555 | 4,999,995 | 3,380,951 | Jan 12, 2016, 04:32 PM |
BAY CITY CAPITAL LLC | 10% Owner | Jan 12, 2016 | Buy | $9.00 | 555,555 | 4,999,995 | 3,380,951 | Jan 12, 2016, 04:30 PM |
Copeland Robert A | President of Research and CSO | Jan 04, 2016 | Option Exercise | $2.28 | 4,185 | 9,559 | 3,893 | Jan 04, 2016, 06:43 PM |
Copeland Robert A | President of Research and CSO | Jan 04, 2016 | Sale | $15.58 | 4,185 | 65,183 | 0 | Jan 04, 2016, 06:43 PM |
Gould Robert J | Director | Dec 30, 2015 | Option Exercise | $0.51 | 11,805 | 6,021 | 11,805 | Dec 31, 2015, 10:23 AM |
Gould Robert J | Director | Dec 29, 2015 | Option Exercise | $0.51 | 20,303 | 10,355 | 20,303 | Dec 31, 2015, 10:23 AM |
Gould Robert J | Director | Dec 30, 2015 | Sale | $18.02 | 11,805 | 212,713 | 0 | Dec 31, 2015, 10:23 AM |
Gould Robert J | Director | Dec 29, 2015 | Sale | $18.01 | 20,303 | 365,618 | 0 | Dec 31, 2015, 10:23 AM |
Ho Peter Tai-Ching | Chief Development Officer | Dec 09, 2015 | Buy | $14.69 | 1,000 | 14,690 | 4,722 | Dec 10, 2015, 05:15 PM |
Copeland Robert A | President of Research and CSO | Dec 07, 2015 | Option Exercise | $1.55 | 4,185 | 6,491 | 2,503 | Dec 08, 2015, 06:26 PM |
Copeland Robert A | President of Research and CSO | Dec 07, 2015 | Sale | $13.82 | 4,185 | 57,843 | 0 | Dec 08, 2015, 06:26 PM |
Copeland Robert A | President of Research and CSO | Nov 09, 2015 | Option Exercise | $0.60 | 4,185 | 2,511 | 4,185 | Nov 10, 2015, 04:10 PM |
Copeland Robert A | President of Research and CSO | Nov 09, 2015 | Sale | $16.26 | 4,185 | 68,059 | 0 | Nov 10, 2015, 04:10 PM |
Copeland Robert A | President of Research and CSO | Oct 05, 2015 | Option Exercise | $0.60 | 4,185 | 2,511 | 4,185 | Oct 05, 2015, 05:43 PM |
Copeland Robert A | President of Research and CSO | Oct 05, 2015 | Sale | $14.43 | 4,185 | 60,380 | 0 | Oct 05, 2015, 05:43 PM |
Copeland Robert A | President of Research and CSO | Sep 08, 2015 | Option Exercise | $0.60 | 4,185 | 2,511 | 4,185 | Sep 10, 2015, 07:21 PM |
Copeland Robert A | President of Research and CSO | Sep 08, 2015 | Sale | $19.58 | 4,185 | 81,921 | 0 | Sep 10, 2015, 07:21 PM |
Gould Robert J | President & CEO | Sep 08, 2015 | Option Exercise | $0.51 | 60,000 | 30,600 | 60,000 | Sep 10, 2015, 07:06 PM |
Gould Robert J | President & CEO | Sep 08, 2015 | Sale | $19.86 | 60,000 | 1,191,742 | 700 | Sep 10, 2015, 07:06 PM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 31, 2015 | Buy | $17.00 | 522 | 8,874 | 3,522 | Sep 02, 2015, 03:30 PM |
Ho Peter Tai-Ching | Chief Development Officer | Aug 20, 2015 | Buy | $16.51 | 2,000 | 33,020 | 3,000 | Aug 24, 2015, 05:38 PM |
Copeland Robert A | President of Research and CSO | Aug 03, 2015 | Option Exercise | $0.60 | 8,370 | 5,022 | 8,370 | Aug 05, 2015, 09:53 PM |
Copeland Robert A | President of Research and CSO | Aug 03, 2015 | Sale | $22.19 | 8,370 | 185,727 | 0 | Aug 05, 2015, 09:53 PM |
Gould Robert J | President & CEO | Aug 03, 2015 | Option Exercise | $0.51 | 60,000 | 30,600 | 60,000 | Aug 05, 2015, 09:38 PM |
Gould Robert J | President & CEO | Aug 03, 2015 | Sale | $21.97 | 60,000 | 1,318,354 | 4,200 | Aug 05, 2015, 09:38 PM |
Copeland Robert A | President of Research and CSO | Jul 06, 2015 | Option Exercise | $0.59 | 8,371 | 4,910 | 8,371 | Jul 08, 2015, 06:13 PM |
Copeland Robert A | President of Research and CSO | Jul 06, 2015 | Sale | $22.86 | 8,371 | 191,398 | 4,185 | Jul 08, 2015, 06:13 PM |
Gould Robert J | President & CEO | Jul 06, 2015 | Option Exercise | $0.51 | 60,000 | 30,600 | 60,000 | Jul 08, 2015, 04:53 PM |
Gould Robert J | President & CEO | Jul 06, 2015 | Sale | $23.22 | 60,000 | 1,393,080 | 15,142 | Jul 08, 2015, 04:53 PM |
Ho Peter Tai-Ching | Chief Development Officer | May 05, 2015 | Buy | $16.36 | 800 | 13,084 | 1,000 | May 06, 2015, 06:03 PM |
Ho Peter Tai-Ching | Chief Development Officer | Dec 16, 2014 | Buy | $17.63 | 400 | 7,052 | 600 | Dec 18, 2014, 06:34 PM |
Ho Peter Tai-Ching | Chief Development Officer | Dec 02, 2014 | Buy | $21.16 | 800 | 16,930 | 400 | Dec 04, 2014, 06:17 PM |
Ho Peter Tai-Ching | Chief Development Officer | Dec 02, 2014 | Buy | $21.19 | 200 | 4,238 | 200 | Dec 04, 2014, 06:17 PM |
Copeland Robert A | EVP and CSO | Nov 17, 2014 | Option Exercise | $2.19 | 20,000 | 43,800 | 20,000 | Nov 19, 2014, 05:39 PM |
Copeland Robert A | EVP and CSO | Nov 17, 2014 | Sale | $22.68 | 20,000 | 453,636 | 0 | Nov 19, 2014, 05:39 PM |
Garbacz Stephen | Principal Accounting Officer | Nov 03, 2014 | Option Exercise | $2.19 | 868 | 1,901 | 13,941 | Nov 04, 2014, 06:35 PM |
Garbacz Stephen | Principal Accounting Officer | Nov 03, 2014 | Sale | $26.44 | 868 | 22,950 | 13,073 | Nov 04, 2014, 06:35 PM |
Copeland Robert A | EVP and CSO | Nov 03, 2014 | Option Exercise | $1.67 | 20,000 | 33,328 | 20,000 | Nov 04, 2014, 06:33 PM |
Copeland Robert A | EVP and CSO | Nov 03, 2014 | Sale | $25.47 | 20,000 | 509,500 | 3,700 | Nov 04, 2014, 06:33 PM |
Gould Robert J | President & CEO | Nov 03, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Nov 04, 2014, 06:31 PM |
Gould Robert J | President & CEO | Nov 03, 2014 | Sale | $24.95 | 30,000 | 748,623 | 5,906 | Nov 04, 2014, 06:31 PM |
Garbacz Stephen | Principal Accounting Officer | Oct 23, 2014 | Option Exercise | $3.54 | 535 | 1,894 | 13,608 | Oct 27, 2014, 06:00 PM |
Garbacz Stephen | Principal Accounting Officer | Oct 23, 2014 | Sale | $30.00 | 535 | 16,050 | 13,073 | Oct 27, 2014, 06:00 PM |
Hedrick Eric | Chief Medical Officer | Oct 15, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 2,429 | Oct 17, 2014, 06:52 PM |
Hedrick Eric | Chief Medical Officer | Oct 15, 2014 | Sale | $23.38 | 2,000 | 46,760 | 429 | Oct 17, 2014, 06:52 PM |
Copeland Robert A | EVP and CSO | Oct 07, 2014 | Option Exercise | $0.60 | 20,000 | 12,000 | 20,000 | Oct 09, 2014, 06:10 PM |
Copeland Robert A | EVP and CSO | Oct 07, 2014 | Sale | $26.90 | 20,000 | 538,031 | 1,000 | Oct 09, 2014, 06:10 PM |
Garbacz Stephen | Principal Accounting Officer | Oct 01, 2014 | Option Exercise | $2.19 | 868 | 1,901 | 13,941 | Oct 03, 2014, 05:54 PM |
Garbacz Stephen | Principal Accounting Officer | Oct 01, 2014 | Sale | $27.06 | 868 | 23,488 | 13,073 | Oct 03, 2014, 05:54 PM |
Gould Robert J | President & CEO | Oct 01, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Oct 03, 2014, 05:51 PM |
Gould Robert J | President & CEO | Oct 01, 2014 | Sale | $26.28 | 30,000 | 788,300 | 500 | Oct 03, 2014, 05:51 PM |
Rhodes Jason P | President, CFO and Treasurer | Sep 22, 2014 | Option Exercise | $0.51 | 44,000 | 22,440 | 138,000 | Sep 24, 2014, 06:15 PM |
Copeland Robert A | EVP and CSO | Sep 22, 2014 | Option Exercise | $0.60 | 20,000 | 12,000 | 20,000 | Sep 24, 2014, 06:14 PM |
Copeland Robert A | EVP and CSO | Sep 22, 2014 | Sale | $25.55 | 20,000 | 510,990 | 0 | Sep 24, 2014, 06:14 PM |
Hedrick Eric | Chief Medical Officer | Sep 15, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 2,429 | Sep 15, 2014, 06:26 PM |
Hedrick Eric | Chief Medical Officer | Sep 15, 2014 | Sale | $28.67 | 2,000 | 57,340 | 429 | Sep 15, 2014, 06:26 PM |
GOLDFISCHER CARL | Director | Sep 04, 2014 | Sale | $35.14 | 4,000 | 140,560 | 2,825,396 | Sep 05, 2014, 07:30 PM |
Rhodes Jason P | President, CFO and Treasurer | Sep 02, 2014 | Option Exercise | $1.02 | 42,000 | 42,840 | 124,000 | Sep 04, 2014, 06:41 PM |
Rhodes Jason P | President, CFO and Treasurer | Sep 02, 2014 | Sale | $33.47 | 30,000 | 1,004,163 | 99,972 | Sep 04, 2014, 06:41 PM |
Gould Robert J | CEO | Sep 02, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Sep 04, 2014, 06:39 PM |
Gould Robert J | CEO | Sep 02, 2014 | Sale | $33.46 | 30,000 | 1,003,901 | 6,967 | Sep 04, 2014, 06:39 PM |
GOLDFISCHER CARL | Director | Aug 26, 2014 | Sale | $35.14 | 200,000 | 7,027,800 | 2,829,136 | Aug 28, 2014, 06:11 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 26, 2014 | Sale | $35.14 | 200,000 | 7,027,800 | 2,829,136 | Aug 28, 2014, 06:09 PM |
GOLDFISCHER CARL | Director | Aug 25, 2014 | Sale | $35.14 | 200,000 | 7,027,803 | 2,830,019 | Aug 25, 2014, 06:29 PM |
GOLDFISCHER CARL | Director | Aug 22, 2014 | Sale | $32.46 | 128,000 | 4,154,765 | 3,027,790 | Aug 25, 2014, 06:29 PM |
GOLDFISCHER CARL | Director | Aug 21, 2014 | Sale | $33.04 | 38,666 | 1,277,339 | 3,154,119 | Aug 25, 2014, 06:29 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 25, 2014 | Sale | $35.14 | 200,000 | 7,027,803 | 2,830,019 | Aug 25, 2014, 06:28 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 22, 2014 | Sale | $32.46 | 128,000 | 4,154,765 | 3,027,790 | Aug 25, 2014, 06:28 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 21, 2014 | Sale | $33.04 | 38,666 | 1,277,339 | 3,154,119 | Aug 25, 2014, 06:28 PM |
Weller Harry R | 10% Owner | Aug 22, 2014 | Option Exercise | $33.40 | 439 | 14,662 | 0 | Aug 25, 2014, 01:49 PM |
Weller Harry R | 10% Owner | Aug 22, 2014 | Option Exercise | $33.45 | 24 | 803 | 0 | Aug 25, 2014, 01:49 PM |
Weller Harry R | 10% Owner | Aug 22, 2014 | Option Exercise | $33.45 | 24 | 803 | 0 | Aug 25, 2014, 01:49 PM |
Hedrick Eric | Chief Medical Officer | Aug 15, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 2,000 | Aug 19, 2014, 06:20 PM |
Hedrick Eric | Chief Medical Officer | Aug 15, 2014 | Sale | $38.60 | 2,000 | 77,200 | 0 | Aug 19, 2014, 06:20 PM |
Copeland Robert A | EVP and CSO | Aug 18, 2014 | Sale | $36.07 | 5,525 | 199,274 | 1,326 | Aug 19, 2014, 06:19 PM |
Copeland Robert A | EVP and CSO | Aug 18, 2014 | Sale | $36.07 | 5,305 | 191,339 | 1,274 | Aug 19, 2014, 06:19 PM |
BARRETT M JAMES | 10% Owner | Aug 15, 2014 | Sale | $36.51 | 3,411 | 124,519 | 384 | Aug 18, 2014, 05:47 PM |
BARRETT M JAMES | 10% Owner | Aug 15, 2014 | Sale | $35.93 | 325 | 11,676 | 0 | Aug 18, 2014, 05:47 PM |
BARRETT M JAMES | 10% Owner | Aug 15, 2014 | Sale | $35.67 | 325 | 11,593 | 0 | Aug 18, 2014, 05:47 PM |
BARRIS PETER J | 10% Owner | Aug 15, 2014 | Sale | $36.51 | 3,411 | 124,519 | 384 | Aug 18, 2014, 05:47 PM |
BASKETT FOREST | 10% Owner | Aug 15, 2014 | Sale | $36.51 | 3,411 | 124,519 | 384 | Aug 18, 2014, 05:47 PM |
BASKETT FOREST | 10% Owner | Aug 15, 2014 | Sale | $37.03 | 559 | 20,699 | 0 | Aug 18, 2014, 05:47 PM |
DRANT RYAN D | 10% Owner | Aug 15, 2014 | Sale | $36.69 | 195 | 7,156 | 0 | Aug 18, 2014, 05:46 PM |
DRANT RYAN D | 10% Owner | Aug 15, 2014 | Sale | $36.72 | 455 | 16,708 | 0 | Aug 18, 2014, 05:46 PM |
DRANT RYAN D | 10% Owner | Aug 15, 2014 | Sale | $36.51 | 3,411 | 124,519 | 384 | Aug 18, 2014, 05:46 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 483 | 17,663 | 0 | Aug 18, 2014, 05:39 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 84 | 3,072 | 0 | Aug 18, 2014, 05:39 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 84 | 3,072 | 0 | Aug 18, 2014, 05:39 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 84 | 3,072 | 0 | Aug 18, 2014, 05:32 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 84 | 3,072 | 0 | Aug 18, 2014, 05:32 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Aug 15, 2014 | Sale | $36.57 | 483 | 17,663 | 0 | Aug 18, 2014, 05:32 PM |
SANDELL SCOTT D | 10% Owner | Aug 15, 2014 | Sale | $36.51 | 3,411 | 124,519 | 384 | Aug 18, 2014, 05:31 PM |
Viswanathan Ravi | 10% Owner | Aug 18, 2014 | Sale | $35.56 | 433 | 15,396 | 0 | Aug 18, 2014, 05:31 PM |
Copeland Robert A | EVP and CSO | Aug 04, 2014 | Option Exercise | $0.60 | 20,000 | 12,000 | 25,305 | Aug 05, 2014, 06:29 PM |
Copeland Robert A | EVP and CSO | Aug 04, 2014 | Sale | $29.42 | 20,000 | 588,347 | 13,732 | Aug 05, 2014, 06:29 PM |
Rhodes Jason P | President, CFO and Treasurer | Aug 04, 2014 | Option Exercise | $1.16 | 42,000 | 48,720 | 112,000 | Aug 05, 2014, 06:28 PM |
Rhodes Jason P | President, CFO and Treasurer | Aug 04, 2014 | Sale | $29.74 | 30,000 | 892,324 | 100,400 | Aug 05, 2014, 06:28 PM |
Gould Robert J | CEO | Aug 01, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Aug 05, 2014, 06:26 PM |
Gould Robert J | CEO | Aug 01, 2014 | Sale | $30.24 | 30,000 | 907,256 | 10,180 | Aug 05, 2014, 06:26 PM |
Hedrick Eric | Chief Medical Officer | Jul 15, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 2,000 | Jul 17, 2014, 06:45 PM |
Hedrick Eric | Chief Medical Officer | Jul 15, 2014 | Sale | $31.35 | 2,000 | 62,700 | 0 | Jul 17, 2014, 06:45 PM |
Rhodes Jason P | President, CFO and Treasurer | Jul 07, 2014 | Option Exercise | $0.95 | 42,000 | 39,960 | 100,000 | Jul 09, 2014, 06:16 PM |
Rhodes Jason P | President, CFO and Treasurer | Jul 07, 2014 | Sale | $32.74 | 30,000 | 982,161 | 76,446 | Jul 09, 2014, 06:16 PM |
Gould Robert J | CEO | Jul 01, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Jul 03, 2014, 06:27 PM |
Gould Robert J | CEO | Jul 01, 2014 | Sale | $31.53 | 30,000 | 945,795 | 400 | Jul 03, 2014, 06:27 PM |
Copeland Robert A | EVP and CSO | Jun 23, 2014 | Option Exercise | $0.57 | 20,000 | 11,411 | 25,305 | Jun 25, 2014, 06:03 PM |
Copeland Robert A | EVP and CSO | Jun 23, 2014 | Sale | $28.42 | 20,000 | 568,412 | 10,489 | Jun 25, 2014, 06:03 PM |
Hedrick Eric | Chief Medical Officer | Jun 16, 2014 | Option Exercise | $2.19 | 2,000 | 4,380 | 2,000 | Jun 18, 2014, 06:08 PM |
Hedrick Eric | Chief Medical Officer | Jun 16, 2014 | Sale | $26.42 | 2,000 | 52,840 | 0 | Jun 18, 2014, 06:08 PM |
Copeland Robert A | EVP and CSO | Jun 16, 2014 | Sale | $26.38 | 12,756 | 336,540 | 5,525 | Jun 18, 2014, 06:06 PM |
Copeland Robert A | EVP and CSO | Jun 16, 2014 | Sale | $26.38 | 12,256 | 323,349 | 5,305 | Jun 18, 2014, 06:06 PM |
Copeland Robert A | EVP and CSO | Jun 02, 2014 | Option Exercise | $0.51 | 38,400 | 19,584 | 55,961 | Jun 04, 2014, 06:06 PM |
Copeland Robert A | EVP and CSO | Jun 02, 2014 | Sale | $22.29 | 38,400 | 856,065 | 20,661 | Jun 04, 2014, 06:06 PM |
Rhodes Jason P | President, CFO and Treasurer | Jun 02, 2014 | Option Exercise | $1.59 | 42,000 | 66,870 | 88,000 | Jun 04, 2014, 06:05 PM |
Rhodes Jason P | President, CFO and Treasurer | Jun 02, 2014 | Sale | $22.20 | 30,000 | 665,870 | 59,264 | Jun 04, 2014, 06:05 PM |
Gould Robert J | CEO | Jun 02, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Jun 04, 2014, 06:03 PM |
Gould Robert J | CEO | Jun 02, 2014 | Sale | $22.20 | 30,000 | 666,060 | 1,200 | Jun 04, 2014, 06:03 PM |
Copeland Robert A | EVP and CSO | May 19, 2014 | Sale | $22.28 | 2,550 | 56,804 | 18,281 | May 21, 2014, 05:58 PM |
Copeland Robert A | EVP and CSO | May 19, 2014 | Sale | $22.28 | 2,450 | 54,576 | 17,561 | May 21, 2014, 05:58 PM |
Copeland Robert A | EVP and CSO | May 05, 2014 | Sale | $21.29 | 10,200 | 217,142 | 20,831 | May 05, 2014, 06:56 PM |
Copeland Robert A | EVP and CSO | May 05, 2014 | Sale | $21.29 | 9,800 | 208,626 | 20,011 | May 05, 2014, 06:56 PM |
Rhodes Jason P | President, CFO and Treasurer | May 05, 2014 | Option Exercise | $3.18 | 42,000 | 133,530 | 76,000 | May 05, 2014, 06:55 PM |
Rhodes Jason P | President, CFO and Treasurer | May 05, 2014 | Sale | $21.53 | 30,000 | 645,840 | 46,000 | May 05, 2014, 06:55 PM |
Gould Robert J | CEO | May 01, 2014 | Option Exercise | $0.51 | 60,000 | 30,600 | 30,000 | May 05, 2014, 06:53 PM |
Gould Robert J | CEO | May 01, 2014 | Sale | $21.91 | 60,000 | 1,314,876 | 1,913 | May 05, 2014, 06:53 PM |
Copeland Robert A | EVP and CSO | Apr 28, 2014 | Option Exercise | $0.51 | 13,800 | 7,038 | 38,711 | Apr 30, 2014, 06:12 PM |
Copeland Robert A | EVP and CSO | Apr 28, 2014 | Sale | $20.73 | 13,800 | 286,085 | 24,911 | Apr 30, 2014, 06:12 PM |
Rhodes Jason P | President, CFO and Treasurer | Apr 07, 2014 | Option Exercise | $0.51 | 35,000 | 17,850 | 59,000 | Apr 08, 2014, 06:42 PM |
Rhodes Jason P | President, CFO and Treasurer | Apr 07, 2014 | Sale | $20.05 | 25,000 | 501,190 | 34,000 | Apr 08, 2014, 06:42 PM |
Gould Robert J | CEO | Apr 07, 2014 | Option Exercise | $0.51 | 30,000 | 15,300 | 30,000 | Apr 08, 2014, 06:41 PM |
Gould Robert J | CEO | Apr 07, 2014 | Sale | $20.22 | 30,000 | 606,738 | 0 | Apr 08, 2014, 06:41 PM |
KPCB XIII Associates, LLC | 10% Owner | Feb 10, 2014 | Sale | $27.64 | 388,584 | 10,740,967 | 3,838,167 | Feb 12, 2014, 08:18 PM |
SEIDENBERG BETH C | Director | Feb 10, 2014 | Sale | $27.64 | 388,584 | 10,740,967 | 3,838,167 | Feb 12, 2014, 08:05 PM |
Hedrick Eric | Chief Medical Officer | Feb 10, 2014 | Option Exercise | $2.19 | 13,500 | 29,565 | 13,500 | Feb 12, 2014, 07:57 PM |
Hedrick Eric | Chief Medical Officer | Feb 10, 2014 | Sale | $29.25 | 13,500 | 394,875 | 0 | Feb 12, 2014, 07:57 PM |
Copeland Robert A | EVP and CSO | Feb 10, 2014 | Sale | $29.25 | 19,179 | 560,986 | 24,911 | Feb 12, 2014, 07:56 PM |
Rhodes Jason P | President, CFO and Treasurer | Feb 10, 2014 | Option Exercise | $2.67 | 70,000 | 187,200 | 74,000 | Feb 12, 2014, 07:55 PM |
Rhodes Jason P | President, CFO and Treasurer | Feb 10, 2014 | Sale | $29.25 | 50,000 | 1,462,500 | 24,000 | Feb 12, 2014, 07:55 PM |
Gould Robert J | CEO | Feb 10, 2014 | Option Exercise | $0.51 | 60,000 | 30,600 | 60,000 | Feb 12, 2014, 07:53 PM |
Gould Robert J | CEO | Feb 10, 2014 | Sale | $29.25 | 60,000 | 1,755,000 | 0 | Feb 12, 2014, 07:53 PM |
GOLDFISCHER CARL | Director | Feb 10, 2014 | Sale | $29.25 | 466,667 | 13,650,010 | 3,200,789 | Feb 12, 2014, 03:01 PM |
BAY CITY CAPITAL LLC | 10% Owner | Feb 10, 2014 | Sale | $29.25 | 466,667 | 13,650,010 | 3,200,789 | Feb 12, 2014, 02:59 PM |
Celgene European Investment Co LLC | 10% Owner | Feb 10, 2014 | Buy | $29.25 | 340,000 | 9,945,000 | 3,674,640 | Feb 11, 2014, 04:23 PM |
MPM BioVentures IV QP LP | 10% Owner | Feb 10, 2014 | Sale | $29.25 | 466,666 | 13,649,981 | 2,413,819 | Feb 11, 2014, 03:56 PM |
EVNIN LUKE | 10% Owner | Feb 10, 2014 | Sale | $29.25 | 466,666 | 13,649,981 | 2,413,819 | Feb 11, 2014, 03:54 PM |
Copeland Robert A | EVP and CSO | Jan 13, 2014 | Sale | $39.27 | 5,552 | 218,016 | 28,197 | Jan 15, 2014, 09:34 PM |
Copeland Robert A | EVP and CSO | Jan 13, 2014 | Sale | $39.27 | 9,454 | 371,238 | 47,948 | Jan 15, 2014, 09:34 PM |
Rhodes Jason P | President, CFO and Treasurer | Jan 06, 2014 | Option Exercise | $0.51 | 14,000 | 7,140 | 14,000 | Jan 06, 2014, 09:34 PM |
Rhodes Jason P | President, CFO and Treasurer | Jan 06, 2014 | Sale | $20.19 | 10,000 | 201,874 | 4,000 | Jan 06, 2014, 09:34 PM |
Gould Robert J | President and CEO | Jan 02, 2014 | Option Exercise | $0.34 | 30,000 | 10,124 | 14,131 | Jan 06, 2014, 09:32 PM |
Gould Robert J | President and CEO | Jan 02, 2014 | Sale | $20.16 | 30,000 | 604,778 | 0 | Jan 06, 2014, 09:32 PM |
Copeland Robert A | EVP and CSO | Dec 16, 2013 | Option Exercise | $2.19 | 4,600 | 10,074 | 58,144 | Dec 17, 2013, 05:53 PM |
Copeland Robert A | EVP and CSO | Dec 16, 2013 | Sale | $21.21 | 4,600 | 97,545 | 53,544 | Dec 17, 2013, 05:53 PM |
Copeland Robert A | EVP and CSO | Dec 02, 2013 | Sale | $20.70 | 1,850 | 38,288 | 31,483 | Dec 03, 2013, 06:04 PM |
Copeland Robert A | EVP and CSO | Dec 02, 2013 | Sale | $20.70 | 3,150 | 65,194 | 53,544 | Dec 03, 2013, 06:04 PM |
Weller Harry R | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:59 AM |
Weller Harry R | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:59 AM |
Viswanathan Ravi | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:59 AM |
Viswanathan Ravi | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:59 AM |
SANDELL SCOTT D | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:58 AM |
SANDELL SCOTT D | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:58 AM |
MOTT DAVID M | Director | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:58 AM |
MOTT DAVID M | Director | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:58 AM |
KOLLURI KRISHNA KITTU | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:58 AM |
KOLLURI KRISHNA KITTU | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:58 AM |
KERINS PATRICK J | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:57 AM |
KERINS PATRICK J | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:57 AM |
DRANT RYAN D | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:57 AM |
DRANT RYAN D | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:57 AM |
BASKETT FOREST | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:57 AM |
BASKETT FOREST | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:57 AM |
BARRIS PETER J | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:56 AM |
BARRIS PETER J | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:56 AM |
BARRETT M JAMES | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:56 AM |
BARRETT M JAMES | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:56 AM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Nov 14, 2013 | Buy | $19.66 | 357,000 | 7,018,527 | 357,000 | Nov 18, 2013, 07:56 AM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Nov 15, 2013 | Buy | $19.79 | 49,500 | 979,454 | 406,500 | Nov 18, 2013, 07:56 AM |
KERINS PATRICK J | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 03:05 PM |
DRANT RYAN D | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 03:02 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 03:01 PM |
BASKETT FOREST | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 03:00 PM |
BARRIS PETER J | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:58 PM |
SANDELL SCOTT D | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:57 PM |
BARRETT M JAMES | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:56 PM |
Viswanathan Ravi | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:36 PM |
Weller Harry R | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:33 PM |
MOTT DAVID M | Director | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:31 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 400,000 | 6,000,000 | 6,033,240 | Jun 07, 2013, 02:30 PM |
GOLDFISCHER CARL | Director | Jun 05, 2013 | Buy | $15.00 | 166,666 | 2,499,990 | 3,658,729 | Jun 07, 2013, 12:51 PM |
BAY CITY CAPITAL LLC | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 166,666 | 2,499,990 | 3,658,729 | Jun 07, 2013, 12:50 PM |
Astellas Venture Fund I L.P. | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 15,333 | 229,995 | 650,253 | Jun 06, 2013, 08:27 PM |
Celgene European Investment Co LLC | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 66,666 | 999,990 | 3,334,640 | Jun 06, 2013, 03:25 PM |
Amgen Ventures LLC | 10% Owner | Jun 05, 2013 | Buy | $15.00 | 16,666 | 249,990 | 334,126 | Jun 05, 2013, 04:01 PM |
Owner | Relationship | Date | Value($) |
Bogle Grant C. | See Remarks | 08/09/2022 | 1,594,434 |
Bogle Grant C. | See Remarks | 08/09/2022 | 1,700,675 |
Agarwal Shefali | See Remarks | 08/09/2022 | 518,684 |
Agarwal Shefali | See Remarks | 08/09/2022 | 695,000 |
Beaulieu Joseph | See Remarks | 08/09/2022 | 389,011 |
Beaulieu Joseph | See Remarks | 08/09/2022 | 417,000 |
Kutok Jeffery | Chief Scientific Officer | 08/09/2022 | 492,749 |
Kutok Jeffery | Chief Scientific Officer | 08/09/2022 | 528,200 |
MOTT DAVID M | Director | 06/30/2022 | 23,749 |
BEVERIDGE, ROY A | Director | 06/30/2022 | 13,124 |
Conroy Kevin T | Director | 06/30/2022 | 15,000 |
Kutok Jeffery | Chief Scientific Officer | 04/11/2022 | 2,467 |
BEVERIDGE, ROY A | Director | 03/31/2022 | 13,125 |
MOTT DAVID M | Director | 03/31/2022 | 23,751 |
Conroy Kevin T | Director | 03/31/2022 | 14,999 |
Beaulieu Joseph | See Remarks | 02/28/2022 | 2,952 |
Agarwal Shefali | See Remarks | 02/28/2022 | 2,952 |
Beaulieu Joseph | Corporate Controller | 02/07/2022 | 333 |
Agarwal Shefali | See Remarks | 02/07/2022 | 1,587 |
Agarwal Shefali | See Remarks | 02/02/2022 | 3,615 |
Kutok Jeffery | Chief Scientific Officer | 02/02/2022 | 3,502 |
Beaulieu Joseph | Corporate Controller | 02/02/2022 | 941 |
Legorreta Pablo G. | Director | 01/31/2022 | 34,000,001 |
Agarwal Shefali | See Remarks | 01/26/2022 | 5,902 |
Agarwal Shefali | See Remarks | 12/06/2021 | 5,215 |
MOTT DAVID M | Director | 09/30/2021 | 23,757 |
Conroy Kevin T | Director | 09/30/2021 | 15,002 |
Conroy Kevin T | Director | 06/30/2021 | 15,000 |
MOTT DAVID M | Director | 06/30/2021 | 23,750 |
Conroy Kevin T | Director | 03/31/2021 | 15,007 |
MOTT DAVID M | Director | 03/31/2021 | 23,752 |
MOTT DAVID M | Director | 03/26/2021 | 274,817 |
MOTT DAVID M | Director | 03/25/2021 | 225,283 |
Bazemore Robert B | President & CEO | 03/25/2021 | 81,075 |
Bazemore Robert B | President & CEO | 02/04/2021 | 43,607 |
Agarwal Shefali | Chief Medical Officer | 02/04/2021 | 10,862 |
TOMBESI PAOLO | Chief Financial Officer | 02/04/2021 | 11,445 |
Beaulieu Joseph | Corporate Controller | 02/04/2021 | 2,545 |
Ros Matthew | See Remarks | 02/04/2021 | 10,022 |
Vakiener Victoria | Chief Commercial Officer | 02/04/2021 | 9,159 |
Bazemore Robert B | President & CEO | 01/25/2021 | 69,247 |
Ros Matthew | See Remarks | 01/25/2021 | 32,770 |
Vakiener Victoria | Chief Commercial Officer | 01/25/2021 | 6,835 |
Agarwal Shefali | Chief Medical Officer | 01/25/2021 | 32,770 |
Conroy Kevin T | Director | 12/31/2020 | 11,121 |
MOTT DAVID M | Director | 12/31/2020 | 23,436 |
Agarwal Shefali | Chief Medical Officer | 12/03/2020 | 34,148 |
GOLDFISCHER CARL | Director | 11/11/2020 | 60,350 |
MOTT DAVID M | Director | 09/30/2020 | 23,442 |
Conroy Kevin T | Director | 09/30/2020 | 11,131 |
Beaulieu Joseph | Corporate Controller | 09/03/2019 | 12,400 |
Beaulieu Joseph | Corporate Controller | 09/02/2020 | 6,994 |
TOMBESI PAOLO | Chief Financial Officer | 08/20/2020 | 26,242 |
MOTT DAVID M | Director | 06/30/2020 | 23,432 |
Conroy Kevin T | Director | 06/30/2020 | 11,130 |
Beaulieu Joseph | Corporate Controller | 06/26/2020 | 5,120 |
Bazemore Robert B | President & CEO | 06/26/2020 | 77,084 |
TOMBESI PAOLO | Chief Financial Officer | 06/26/2020 | 29,151 |
Agarwal Shefali | Chief Medical Officer | 06/26/2020 | 29,151 |
Ros Matthew | See Remarks | 06/26/2020 | 44,057 |
MOTT DAVID M | Director | 06/26/2020 | 994,165 |
Bazemore Robert B | President & CEO | 06/18/2020 | 89,800 |
Bazemore Robert B | President & CEO | 06/18/2020 | 440,000 |
Ros Matthew | See Remarks | 06/18/2020 | 1,060,669 |
Ros Matthew | See Remarks | 06/18/2020 | 2,378,444 |
MOTT DAVID M | Director | 03/31/2020 | 23,451 |
Conroy Kevin T | Director | 03/31/2020 | 11,121 |
Beaulieu Joseph | Corporate Controller | 03/25/2020 | 3,239 |
TOMBESI PAOLO | Chief Financial Officer | 03/25/2020 | 18,993 |
Ros Matthew | See Remarks | 03/25/2020 | 18,993 |
Bazemore Robert B | President & CEO | 03/25/2020 | 50,195 |
Agarwal Shefali | Chief Medical Officer | 03/25/2020 | 18,993 |
Allen Andrew R | Director | 03/16/2020 | 116,625 |
Beaulieu Joseph | Corporate Controller | 03/03/2020 | 22,091 |
Legorreta Pablo G. | Director | 02/11/2020 | 50,000,000 |
Agarwal Shefali | Chief Medical Officer | 01/27/2020 | 53,757 |
Agarwal Shefali | Chief Medical Officer | 01/24/2020 | 45,412 |
Ros Matthew | See Remarks | 01/24/2020 | 53,648 |
Ros Matthew | See Remarks | 01/24/2020 | 45,510 |
Bazemore Robert B | President & CEO | 01/27/2020 | 124,153 |
Bazemore Robert B | President & CEO | 01/24/2020 | 73,909 |
Beaulieu Joseph | Corporate Controller | 01/24/2020 | 8,128 |
TOMBESI PAOLO | Chief Financial Officer | 01/23/2020 | 45,371 |
MOTT DAVID M | Director | 12/31/2019 | 23,419 |
Conroy Kevin T | Director | 12/31/2019 | 11,119 |
MOTT DAVID M | Director | 09/30/2019 | 23,437 |
Conroy Kevin T | Director | 09/30/2019 | 11,125 |
MOTT DAVID M | Director | 06/30/2019 | 23,443 |
SEIDENBERG BETH C | Director | 06/30/2019 | 12,676 |
Conroy Kevin T | Director | 06/30/2019 | 11,132 |
MOTT DAVID M | Director | 06/27/2019 | 652,134 |
MOTT DAVID M | Director | 06/26/2019 | 674,176 |
MOTT DAVID M | Director | 06/25/2019 | 698,649 |
Agarwal Shefali | Chief Medical Officer | 06/14/2019 | 14,304 |
Beaulieu Joseph | Corporate Controller | 06/13/2019 | 2,456 |
Ros Matthew | See Remarks | 06/13/2019 | 14,339 |
Bazemore Robert B | President & CEO | 06/13/2019 | 25,095 |
MOTT DAVID M | Director | 03/31/2019 | 23,429 |
SEIDENBERG BETH C | Director | 03/31/2019 | 12,687 |
Conroy Kevin T | Director | 03/31/2019 | 11,114 |
MOTT DAVID M | Director | 10/05/2018 | 3,750,003 |
SEIDENBERG BETH C | Director | 07/02/2018 | 43,997 |
MOTT DAVID M | Director | 07/02/2018 | 82,492 |
Conroy Kevin T | Director | 07/02/2018 | 38,997 |
Ros Matthew | Chief Operating Officer | 02/05/2018 | 692,289 |
Ros Matthew | Chief Operating Officer | 02/05/2018 | 1,201,695 |
Ho Peter Tai-Ching | Chief Development Officer | 10/24/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 10/24/2017 | 246,591 |
Ho Peter Tai-Ching | Chief Development Officer | 09/25/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 09/25/2017 | 252,076 |
MOTT DAVID M | Director | 09/18/2017 | 3,050,000 |
Ho Peter Tai-Ching | Chief Development Officer | 08/24/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 08/24/2017 | 235,266 |
Ho Peter Tai-Ching | Chief Development Officer | 07/24/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 07/24/2017 | 201,571 |
Singer Andrew E. | EVP & CFO | 06/30/2017 | 46,872 |
Ho Peter Tai-Ching | Chief Development Officer | 06/26/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 06/26/2017 | 223,115 |
Copeland Robert A | President of Research and CSO | 06/06/2017 | 8,850 |
Copeland Robert A | President of Research and CSO | 06/06/2017 | 33,625 |
Ho Peter Tai-Ching | Chief Development Officer | 05/25/2017 | 134,700 |
Ho Peter Tai-Ching | Chief Development Officer | 05/25/2017 | 241,664 |
Copeland Robert A | President of Research and CSO | 05/02/2017 | 17,700 |
Copeland Robert A | President of Research and CSO | 05/02/2017 | 87,212 |
Copeland Robert A | President of Research and CSO | 04/04/2017 | 15,000 |
Copeland Robert A | President of Research and CSO | 04/04/2017 | 81,805 |
Singer Andrew E. | EVP & CFO | 03/31/2017 | 34,394 |
Ros Matthew | Chief Operating Officer | 02/28/2017 | 10,613 |
Ho Peter Tai-Ching | Chief Development Officer | 02/28/2017 | 10,613 |
Singer Andrew E. | EVP & CFO | 01/09/2017 | 12,194 |
Ho Peter Tai-Ching | Chief Development Officer | 12/08/2016 | 2,179 |
Singer Andrew E. | EVP & CFO | 12/09/2016 | 11,172 |
Singer Andrew E. | EVP & CFO | 11/09/2016 | 10,535 |
Singer Andrew E. | EVP & CFO | 10/10/2016 | 9,848 |
Singer Andrew E. | EVP & CFO | 09/09/2016 | 7,651 |
Ho Peter Tai-Ching | Chief Development Officer | 08/31/2016 | 8,463 |
Bazemore Robert B | President & CEO | 08/31/2016 | 8,463 |
Singer Andrew E. | EVP & CFO | 08/09/2016 | 9,166 |
Copeland Robert A | President of Research and CSO | 08/01/2016 | 8,760 |
Copeland Robert A | President of Research and CSO | 08/01/2016 | 41,492 |
Singer Andrew E. | EVP & CFO | 07/11/2016 | 10,494 |
Copeland Robert A | President of Research and CSO | 07/05/2016 | 8,760 |
Copeland Robert A | President of Research and CSO | 07/05/2016 | 40,128 |
MOTT DAVID M | Director | 07/01/2016 | 61,980 |
SEIDENBERG BETH C | Director | 07/01/2016 | 33,056 |
Singer Andrew E. | EVP & CFO | 06/09/2016 | 12,656 |
Copeland Robert A | President of Research and CSO | 06/01/2016 | 111,645 |
Singer Andrew E. | EVP & CFO | 05/09/2016 | 9,914 |
Singer Andrew E. | EVP & CFO | 04/12/2016 | 2,100 |
Singer Andrew E. | EVP & CFO | 04/11/2016 | 10,483 |
Singer Andrew E. | EVP & CFO | 04/12/2016 | 2,100 |
Singer Andrew E. | EVP & CFO | 04/11/2016 | 10,483 |
Ho Peter Tai-Ching | Chief Development Officer | 08/20/2015 | 33,020 |
Singer Andrew E. | EVP & CFO | 03/09/2016 | 9,386 |
Ho Peter Tai-Ching | Chief Development Officer | 02/29/2016 | 4,752 |
Singer Andrew E. | EVP & CFO | 02/10/2016 | 115,987 |
Weller Harry R | 10% Owner | 01/12/2016 | 9,999,999 |
Viswanathan Ravi | 10% Owner | 01/12/2016 | 9,999,999 |
SANDELL SCOTT D | 10% Owner | 01/12/2016 | 9,999,999 |
MOTT DAVID M | Director | 01/12/2016 | 9,999,999 |
KOLLURI KRISHNA KITTU | 10% Owner | 01/12/2016 | 9,999,999 |
KERINS PATRICK J | 10% Owner | 01/12/2016 | 9,999,999 |
BASKETT FOREST | 10% Owner | 01/12/2016 | 9,999,999 |
BARRIS PETER J | 10% Owner | 01/12/2016 | 9,999,999 |
BARRETT M JAMES | 10% Owner | 01/12/2016 | 9,999,999 |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 01/12/2016 | 9,999,999 |
GOLDFISCHER CARL | Director | 01/12/2016 | 4,999,995 |
BAY CITY CAPITAL LLC | 10% Owner | 01/12/2016 | 4,999,995 |
Copeland Robert A | President of Research and CSO | 01/04/2016 | 9,559 |
Copeland Robert A | President of Research and CSO | 01/04/2016 | 65,183 |
Gould Robert J | Director | 12/30/2015 | 6,021 |
Gould Robert J | Director | 12/29/2015 | 10,355 |
Gould Robert J | Director | 12/30/2015 | 212,713 |
Gould Robert J | Director | 12/29/2015 | 365,618 |
Ho Peter Tai-Ching | Chief Development Officer | 12/09/2015 | 14,690 |
Copeland Robert A | President of Research and CSO | 12/07/2015 | 6,491 |
Copeland Robert A | President of Research and CSO | 12/07/2015 | 57,843 |
Copeland Robert A | President of Research and CSO | 11/09/2015 | 2,511 |
Copeland Robert A | President of Research and CSO | 11/09/2015 | 68,059 |
Copeland Robert A | President of Research and CSO | 10/05/2015 | 2,511 |
Copeland Robert A | President of Research and CSO | 10/05/2015 | 60,380 |
Copeland Robert A | President of Research and CSO | 09/08/2015 | 2,511 |
Copeland Robert A | President of Research and CSO | 09/08/2015 | 81,921 |
Gould Robert J | President & CEO | 09/08/2015 | 30,600 |
Gould Robert J | President & CEO | 09/08/2015 | 1,191,742 |
Ho Peter Tai-Ching | Chief Development Officer | 08/31/2015 | 8,874 |
Ho Peter Tai-Ching | Chief Development Officer | 08/20/2015 | 33,020 |
Copeland Robert A | President of Research and CSO | 08/03/2015 | 5,022 |
Copeland Robert A | President of Research and CSO | 08/03/2015 | 185,727 |
Gould Robert J | President & CEO | 08/03/2015 | 30,600 |
Gould Robert J | President & CEO | 08/03/2015 | 1,318,354 |
Copeland Robert A | President of Research and CSO | 07/06/2015 | 4,910 |
Copeland Robert A | President of Research and CSO | 07/06/2015 | 191,398 |
Gould Robert J | President & CEO | 07/06/2015 | 30,600 |
Gould Robert J | President & CEO | 07/06/2015 | 1,393,080 |
Ho Peter Tai-Ching | Chief Development Officer | 05/05/2015 | 13,084 |
Ho Peter Tai-Ching | Chief Development Officer | 12/16/2014 | 7,052 |
Ho Peter Tai-Ching | Chief Development Officer | 12/02/2014 | 16,930 |
Ho Peter Tai-Ching | Chief Development Officer | 12/02/2014 | 4,238 |
Copeland Robert A | EVP and CSO | 11/17/2014 | 43,800 |
Copeland Robert A | EVP and CSO | 11/17/2014 | 453,636 |
Garbacz Stephen | Principal Accounting Officer | 11/03/2014 | 1,901 |
Garbacz Stephen | Principal Accounting Officer | 11/03/2014 | 22,950 |
Copeland Robert A | EVP and CSO | 11/03/2014 | 33,328 |
Copeland Robert A | EVP and CSO | 11/03/2014 | 509,500 |
Gould Robert J | President & CEO | 11/03/2014 | 15,300 |
Gould Robert J | President & CEO | 11/03/2014 | 748,623 |
Garbacz Stephen | Principal Accounting Officer | 10/23/2014 | 1,894 |
Garbacz Stephen | Principal Accounting Officer | 10/23/2014 | 16,050 |
Hedrick Eric | Chief Medical Officer | 10/15/2014 | 4,380 |
Hedrick Eric | Chief Medical Officer | 10/15/2014 | 46,760 |
Copeland Robert A | EVP and CSO | 10/07/2014 | 12,000 |
Copeland Robert A | EVP and CSO | 10/07/2014 | 538,031 |
Garbacz Stephen | Principal Accounting Officer | 10/01/2014 | 1,901 |
Garbacz Stephen | Principal Accounting Officer | 10/01/2014 | 23,488 |
Gould Robert J | President & CEO | 10/01/2014 | 15,300 |
Gould Robert J | President & CEO | 10/01/2014 | 788,300 |
Rhodes Jason P | President, CFO and Treasurer | 09/22/2014 | 22,440 |
Copeland Robert A | EVP and CSO | 09/22/2014 | 12,000 |
Copeland Robert A | EVP and CSO | 09/22/2014 | 510,990 |
Hedrick Eric | Chief Medical Officer | 09/15/2014 | 4,380 |
Hedrick Eric | Chief Medical Officer | 09/15/2014 | 57,340 |
GOLDFISCHER CARL | Director | 09/04/2014 | 140,560 |
Rhodes Jason P | President, CFO and Treasurer | 09/02/2014 | 42,840 |
Rhodes Jason P | President, CFO and Treasurer | 09/02/2014 | 1,004,163 |
Gould Robert J | CEO | 09/02/2014 | 15,300 |
Gould Robert J | CEO | 09/02/2014 | 1,003,901 |
GOLDFISCHER CARL | Director | 08/26/2014 | 7,027,800 |
BAY CITY CAPITAL LLC | 10% Owner | 08/26/2014 | 7,027,800 |
GOLDFISCHER CARL | Director | 08/25/2014 | 7,027,803 |
GOLDFISCHER CARL | Director | 08/22/2014 | 4,154,765 |
GOLDFISCHER CARL | Director | 08/21/2014 | 1,277,339 |
BAY CITY CAPITAL LLC | 10% Owner | 08/25/2014 | 7,027,803 |
BAY CITY CAPITAL LLC | 10% Owner | 08/22/2014 | 4,154,765 |
BAY CITY CAPITAL LLC | 10% Owner | 08/21/2014 | 1,277,339 |
Weller Harry R | 10% Owner | 08/22/2014 | 14,662 |
Weller Harry R | 10% Owner | 08/22/2014 | 803 |
Weller Harry R | 10% Owner | 08/22/2014 | 803 |
Hedrick Eric | Chief Medical Officer | 08/15/2014 | 4,380 |
Hedrick Eric | Chief Medical Officer | 08/15/2014 | 77,200 |
Copeland Robert A | EVP and CSO | 08/18/2014 | 199,274 |
Copeland Robert A | EVP and CSO | 08/18/2014 | 191,339 |
BARRETT M JAMES | 10% Owner | 08/15/2014 | 124,519 |
BARRETT M JAMES | 10% Owner | 08/15/2014 | 11,676 |
BARRETT M JAMES | 10% Owner | 08/15/2014 | 11,593 |
BARRIS PETER J | 10% Owner | 08/15/2014 | 124,519 |
BASKETT FOREST | 10% Owner | 08/15/2014 | 124,519 |
BASKETT FOREST | 10% Owner | 08/15/2014 | 20,699 |
DRANT RYAN D | 10% Owner | 08/15/2014 | 7,156 |
DRANT RYAN D | 10% Owner | 08/15/2014 | 16,708 |
DRANT RYAN D | 10% Owner | 08/15/2014 | 124,519 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 17,663 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 3,072 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 3,072 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 3,072 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 3,072 |
KOLLURI KRISHNA KITTU | 10% Owner | 08/15/2014 | 17,663 |
SANDELL SCOTT D | 10% Owner | 08/15/2014 | 124,519 |
Viswanathan Ravi | 10% Owner | 08/18/2014 | 15,396 |
Copeland Robert A | EVP and CSO | 08/04/2014 | 12,000 |
Copeland Robert A | EVP and CSO | 08/04/2014 | 588,347 |
Rhodes Jason P | President, CFO and Treasurer | 08/04/2014 | 48,720 |
Rhodes Jason P | President, CFO and Treasurer | 08/04/2014 | 892,324 |
Gould Robert J | CEO | 08/01/2014 | 15,300 |
Gould Robert J | CEO | 08/01/2014 | 907,256 |
Hedrick Eric | Chief Medical Officer | 07/15/2014 | 4,380 |
Hedrick Eric | Chief Medical Officer | 07/15/2014 | 62,700 |
Rhodes Jason P | President, CFO and Treasurer | 07/07/2014 | 39,960 |
Rhodes Jason P | President, CFO and Treasurer | 07/07/2014 | 982,161 |
Gould Robert J | CEO | 07/01/2014 | 15,300 |
Gould Robert J | CEO | 07/01/2014 | 945,795 |
Copeland Robert A | EVP and CSO | 06/23/2014 | 11,411 |
Copeland Robert A | EVP and CSO | 06/23/2014 | 568,412 |
Hedrick Eric | Chief Medical Officer | 06/16/2014 | 4,380 |
Hedrick Eric | Chief Medical Officer | 06/16/2014 | 52,840 |
Copeland Robert A | EVP and CSO | 06/16/2014 | 336,540 |
Copeland Robert A | EVP and CSO | 06/16/2014 | 323,349 |
Copeland Robert A | EVP and CSO | 06/02/2014 | 19,584 |
Copeland Robert A | EVP and CSO | 06/02/2014 | 856,065 |
Rhodes Jason P | President, CFO and Treasurer | 06/02/2014 | 66,870 |
Rhodes Jason P | President, CFO and Treasurer | 06/02/2014 | 665,870 |
Gould Robert J | CEO | 06/02/2014 | 15,300 |
Gould Robert J | CEO | 06/02/2014 | 666,060 |
Copeland Robert A | EVP and CSO | 05/19/2014 | 56,804 |
Copeland Robert A | EVP and CSO | 05/19/2014 | 54,576 |
Copeland Robert A | EVP and CSO | 05/05/2014 | 217,142 |
Copeland Robert A | EVP and CSO | 05/05/2014 | 208,626 |
Rhodes Jason P | President, CFO and Treasurer | 05/05/2014 | 133,530 |
Rhodes Jason P | President, CFO and Treasurer | 05/05/2014 | 645,840 |
Gould Robert J | CEO | 05/01/2014 | 30,600 |
Gould Robert J | CEO | 05/01/2014 | 1,314,876 |
Copeland Robert A | EVP and CSO | 04/28/2014 | 7,038 |
Copeland Robert A | EVP and CSO | 04/28/2014 | 286,085 |
Rhodes Jason P | President, CFO and Treasurer | 04/07/2014 | 17,850 |
Rhodes Jason P | President, CFO and Treasurer | 04/07/2014 | 501,190 |
Gould Robert J | CEO | 04/07/2014 | 15,300 |
Gould Robert J | CEO | 04/07/2014 | 606,738 |
KPCB XIII Associates, LLC | 10% Owner | 02/10/2014 | 10,740,967 |
SEIDENBERG BETH C | Director | 02/10/2014 | 10,740,967 |
Hedrick Eric | Chief Medical Officer | 02/10/2014 | 29,565 |
Hedrick Eric | Chief Medical Officer | 02/10/2014 | 394,875 |
Copeland Robert A | EVP and CSO | 02/10/2014 | 560,986 |
Rhodes Jason P | President, CFO and Treasurer | 02/10/2014 | 187,200 |
Rhodes Jason P | President, CFO and Treasurer | 02/10/2014 | 1,462,500 |
Gould Robert J | CEO | 02/10/2014 | 30,600 |
Gould Robert J | CEO | 02/10/2014 | 1,755,000 |
GOLDFISCHER CARL | Director | 02/10/2014 | 13,650,010 |
BAY CITY CAPITAL LLC | 10% Owner | 02/10/2014 | 13,650,010 |
Celgene European Investment Co LLC | 10% Owner | 02/10/2014 | 9,945,000 |
MPM BioVentures IV QP LP | 10% Owner | 02/10/2014 | 13,649,981 |
EVNIN LUKE | 10% Owner | 02/10/2014 | 13,649,981 |
Copeland Robert A | EVP and CSO | 01/13/2014 | 218,016 |
Copeland Robert A | EVP and CSO | 01/13/2014 | 371,238 |
Rhodes Jason P | President, CFO and Treasurer | 01/06/2014 | 7,140 |
Rhodes Jason P | President, CFO and Treasurer | 01/06/2014 | 201,874 |
Gould Robert J | President and CEO | 01/02/2014 | 10,124 |
Gould Robert J | President and CEO | 01/02/2014 | 604,778 |
Copeland Robert A | EVP and CSO | 12/16/2013 | 10,074 |
Copeland Robert A | EVP and CSO | 12/16/2013 | 97,545 |
Copeland Robert A | EVP and CSO | 12/02/2013 | 38,288 |
Copeland Robert A | EVP and CSO | 12/02/2013 | 65,194 |
Weller Harry R | 10% Owner | 11/15/2013 | 979,454 |
Weller Harry R | 10% Owner | 11/14/2013 | 7,018,527 |
Viswanathan Ravi | 10% Owner | 11/14/2013 | 7,018,527 |
Viswanathan Ravi | 10% Owner | 11/15/2013 | 979,454 |
SANDELL SCOTT D | 10% Owner | 11/15/2013 | 979,454 |
SANDELL SCOTT D | 10% Owner | 11/14/2013 | 7,018,527 |
MOTT DAVID M | Director | 11/15/2013 | 979,454 |
MOTT DAVID M | Director | 11/14/2013 | 7,018,527 |
KOLLURI KRISHNA KITTU | 10% Owner | 11/15/2013 | 979,454 |
KOLLURI KRISHNA KITTU | 10% Owner | 11/14/2013 | 7,018,527 |
KERINS PATRICK J | 10% Owner | 11/15/2013 | 979,454 |
KERINS PATRICK J | 10% Owner | 11/14/2013 | 7,018,527 |
DRANT RYAN D | 10% Owner | 11/15/2013 | 979,454 |
DRANT RYAN D | 10% Owner | 11/14/2013 | 7,018,527 |
BASKETT FOREST | 10% Owner | 11/15/2013 | 979,454 |
BASKETT FOREST | 10% Owner | 11/14/2013 | 7,018,527 |
BARRIS PETER J | 10% Owner | 11/15/2013 | 979,454 |
BARRIS PETER J | 10% Owner | 11/14/2013 | 7,018,527 |
BARRETT M JAMES | 10% Owner | 11/15/2013 | 979,454 |
BARRETT M JAMES | 10% Owner | 11/14/2013 | 7,018,527 |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 11/14/2013 | 7,018,527 |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 11/15/2013 | 979,454 |
KERINS PATRICK J | 10% Owner | 06/05/2013 | 6,000,000 |
DRANT RYAN D | 10% Owner | 06/05/2013 | 6,000,000 |
KOLLURI KRISHNA KITTU | 10% Owner | 06/05/2013 | 6,000,000 |
BASKETT FOREST | 10% Owner | 06/05/2013 | 6,000,000 |
BARRIS PETER J | 10% Owner | 06/05/2013 | 6,000,000 |
SANDELL SCOTT D | 10% Owner | 06/05/2013 | 6,000,000 |
BARRETT M JAMES | 10% Owner | 06/05/2013 | 6,000,000 |
Viswanathan Ravi | 10% Owner | 06/05/2013 | 6,000,000 |
Weller Harry R | 10% Owner | 06/05/2013 | 6,000,000 |
MOTT DAVID M | Director | 06/05/2013 | 6,000,000 |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | 06/05/2013 | 6,000,000 |
GOLDFISCHER CARL | Director | 06/05/2013 | 2,499,990 |
BAY CITY CAPITAL LLC | 10% Owner | 06/05/2013 | 2,499,990 |
Astellas Venture Fund I L.P. | 10% Owner | 06/05/2013 | 229,995 |
Celgene European Investment Co LLC | 10% Owner | 06/05/2013 | 999,990 |
Amgen Ventures LLC | 10% Owner | 06/05/2013 | 249,990 |